CA2136646A1 - Anti-inflammatory agent - Google Patents

Anti-inflammatory agent

Info

Publication number
CA2136646A1
CA2136646A1 CA002136646A CA2136646A CA2136646A1 CA 2136646 A1 CA2136646 A1 CA 2136646A1 CA 002136646 A CA002136646 A CA 002136646A CA 2136646 A CA2136646 A CA 2136646A CA 2136646 A1 CA2136646 A1 CA 2136646A1
Authority
CA
Canada
Prior art keywords
factor viii
viii
hours
group
ukg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002136646A
Other languages
English (en)
French (fr)
Inventor
David Russell Blake
Christopher John Morris
Richard Bartholomew Williams
Paul Graham Winyard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2136646A1 publication Critical patent/CA2136646A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002136646A 1992-06-01 1993-05-14 Anti-inflammatory agent Abandoned CA2136646A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929211538A GB9211538D0 (en) 1992-06-01 1992-06-01 Antiinflammatory agent
GB9211538.5 1992-06-01

Publications (1)

Publication Number Publication Date
CA2136646A1 true CA2136646A1 (en) 1993-12-09

Family

ID=10716311

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002136646A Abandoned CA2136646A1 (en) 1992-06-01 1993-05-14 Anti-inflammatory agent

Country Status (6)

Country Link
EP (1) EP0648125A1 (ja)
JP (1) JPH07507289A (ja)
AU (1) AU4080193A (ja)
CA (1) CA2136646A1 (ja)
GB (1) GB9211538D0 (ja)
WO (1) WO1993024137A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504074C2 (sv) * 1993-07-05 1996-11-04 Pharmacia Ab Proteinberedning för subkutan, intramuskulär eller intradermal administrering
IL113010A0 (en) * 1994-03-31 1995-10-31 Pharmacia Ab Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
SE503424C2 (sv) * 1994-11-14 1996-06-10 Pharmacia Ab Process för rening av rekombinant koagulationsfaktor VIII
SE9403915D0 (sv) * 1994-11-14 1994-11-14 Annelie Almstedt Process A
JP4663837B2 (ja) * 1999-12-24 2011-04-06 一般財団法人化学及血清療法研究所 第▲ｖｉｉｉ▼因子を主成分とする血小板減少に伴う出血疾患の予防・治療用医薬組成物

Also Published As

Publication number Publication date
EP0648125A1 (en) 1995-04-19
AU4080193A (en) 1993-12-30
WO1993024137A1 (en) 1993-12-09
GB9211538D0 (en) 1992-07-15
JPH07507289A (ja) 1995-08-10

Similar Documents

Publication Publication Date Title
US10772963B2 (en) Etanercept formulations stabilized with xylitol
JP7329571B2 (ja) Ｉｌ－２医薬組成物
EP0722737B1 (en) Use of HGF for the preparation of a medicament against CNS disorders
CA2156255C (en) Soluble thrombomodulin-containing composition
AT391812B (de) Verfahren zur herstellung einer parenteralen t-pa-loesung
US11779635B2 (en) Subcutaneous administration of ADAMTS13
US20020192794A1 (en) Process for the production of a reversibly inactive acidified plasmin composition
IE64080B1 (en) Pharmaceutical for subcutaneous administration containing polypeptides
CH665356A5 (de) Pharmazeutische formulierung.
US10485869B2 (en) Etanercept formulations stabilized with meglumine
CA2136646A1 (en) Anti-inflammatory agent
JP3802104B2 (ja) 脊髄損傷に伴う神経障害の予防・治療剤
US5510390A (en) Anti-hypertensive composition and methods of treatment
KR20210095141A (ko) 지에이엠티 결핍 치료를 위한 아르기닌 결핍 요법
GB2267435A (en) Factor VIII
US20140162958A1 (en) Copolymer-1 Composition and Methods of Use
WO1993007890A1 (en) Treatment of haemophilia
US11497795B2 (en) Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent
EP3858371A1 (en) Medication for alleviating symptoms of peripheral neuropathy caused by anticancer drug and/or suppressing onset of peripheral neuropathy
JPH08283174A (ja) 脊髄損傷後の神経障害に対する治療剤
NZ751610B2 (en) Subcutaneous administration of adamts13
NZ712440B2 (en) Subcutaneous administration of adamts13
JPH04173744A (ja) 神経細胞保護剤
NZ749570B2 (en) Subcutaneous administration of adamts13

Legal Events

Date Code Title Description
FZDE Dead